|
RFX5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.638300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.06669999999587E-05 |
| Normal-vs-Stage2 |
7.917600E-01 |
| Normal-vs-Stage3 |
3.963100E-03 |
| Normal-vs-Stage4 |
2.529600E-01 |
| Stage1-vs-Stage2 |
7.285900E-02 |
| Stage1-vs-Stage3 |
8.924400E-01 |
| Stage1-vs-Stage4 |
1.500590E-01 |
| Stage2-vs-Stage3 |
9.872000E-02 |
| Stage2-vs-Stage4 |
5.654600E-01 |
| Stage3-vs-Stage4 |
2.435400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.400200E-04 |
| Normal-vs-AfricanAmerican |
4.630300E-02 |
| Normal-vs-Asian |
5.457600E-01 |
| Caucasian-vs-AfricanAmerican |
9.580800E-01 |
| Caucasian-vs-Asian |
1.377360E-01 |
| AfricanAmerican-vs-Asian |
1.545950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.595900E-04 |
| Normal-vs-Female |
1.195960E-02 |
| Male-vs-Female |
4.672400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.079900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.318000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.559700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.478600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.051200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.480600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.281600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.897200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.935800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.066800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.820000E-01 |
| Normal-vs-Grade 2 |
8.23090000000581E-05 |
| Normal-vs-Grade 3 |
1.280310E-02 |
| Normal-vs-Grade 4 |
5.713800E-01 |
| Grade 1-vs-Grade 2 |
4.807000E-01 |
| Grade 1-vs-Grade 3 |
8.307800E-01 |
| Grade 1-vs-Grade 4 |
6.829600E-01 |
| Grade 2-vs-Grade 3 |
2.650000E-01 |
| Grade 2-vs-Grade 4 |
8.614300E-02 |
| Grade 3-vs-Grade 4 |
2.791000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.995950E-02 |
| Normal-vs-ccB subtype |
1.418720E-03 |
| ccA subtype-vs-ccB subtype |
2.740000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.101600E-02 |
| Normal-vs-N1 |
5.482400E-01 |
| N0-vs-N1 |
1.257570E-01 |
|
|
